Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Lebrikizumab (Ebglyss) and dupilumab (Dupixent) are both injectable medications used to treat moderate-to-severe eczema. Both medications work by blocking proteins that play a role in causing inflammation. However, they have some important differences. Lebrikizumab is specifically approved for eczema in people 12 years and older, whereas dupilumab is approved for a broader range of conditions, including asthma, sinus congestion with nasal polyps, eosinophilic esophagitis, and prurigo nodularis, and can be used in children as young as 6 months for eczema. Lebrikizumab is injected every 4 weeks for maintenance, while dupilumab can be injected every 1 to 4 weeks, depending on the condition. Common side effects of lebrikizumab include pink eye and injection site reactions, whereas dupilumab may cause eye inflammation and joint pain. Both medications require caution with live vaccines due to potential interactions.
Ebglyss (lebrikizumab)
Dupixent (dupilumab)
Ebglyss (lebrikizumab)
Dupixent (dupilumab)
Summary of Ebglyss vs. Dupixent
Summary for Interleukin-13 antagonist
Prescription only
Ebglyss (lebrikizumab or lebrikizumab-lbkz) is an injectable medication that’s used to treat moderate-to-severe eczema. It’s approved for people 12 years of age and older who weigh at least 88 lbs. This medication is an interleukin-13 antagonist, which works to reduce swelling and discomfort of the skin caused by eczema. Ebglyss (lebrikizumab) is used when topical products aren’t working well enough or when you can’t use them at all. Some people have had side effects like pink eye and pain around the injection site while using Ebglyss (lebrikizumab).
Summary for Interleukin antagonist
Prescription only
Dupixent (dupilumab) is an injection that helps treat certain inflammatory conditions. This includes eczema, asthma, and chronic obstructive pulmonary disease (COPD), among others. It's a biologic medication known as an interleukin antagonist that lowers inflammation. Dupixent (dupilumab) comes as prefilled pens and prefilled syringes. It's injected under the skin of the belly or thighs (or in the back of the upper arm with someone's help). The dosing schedule depends on the condition you have, your age, and your weight. It's injected either every week, every 2 weeks, or every 4 weeks. Side effects include injection site reactions and eye problems.